Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lofexidine for Opioid Withdrawal Management during Naltrexone Induction
NCT04056182Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lofexidine in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Sep 2019; status: completed.
02
Drugs
lofexidine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04056182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056182.